Sphera Funds Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,595
| Closed | -$236K | – | 166 |
|
|
2021
Q1 | $236K | Buy |
+1,595
| New | +$236K | 0.02% | 157 |
|
|
2020
Q4 | – | Sell |
-7,500
| Closed | -$1.14M | – | 127 |
|
|
2020
Q3 | $1.14M | Hold |
7,500
| – | – | 0.11% | 79 |
|
|
2020
Q2 | $1.32M | Buy |
+7,500
| New | +$1.32M | 0.12% | 71 |
|
|
2015
Q2 | – | Sell |
-469
| Closed | -$476K | – | 155 |
|
|
2015
Q1 | $476K | Buy |
+469
| New | +$476K | 0.05% | 132 |
|